Cutaneous Leishmaniasis in Canine and Human Beings
World Small Animal Veterinary Association World Congress Proceedings, 2005
Anil Ahuja1; A.K. Gahlot2; S.K. Purohit3; R.A. Bumb4; R.D. Mehta5
Department of Clinical Veterinary Medicine, College of Veterinary and Animal Science, Bikaner (Rajasthan)
Rajasthan, India

Cutaneous leishmaniasis is caused by a protozoan parasite-Leishmania tropica in dogs and human being both and commonly known as oriental sore. This disease is a type of metazoonosis and is of great zoonotic importance. It is transmitted by sand fly (Phlebotomus spp.) between dogs and men. The disease is characterized by non healing cutaneous/mucocutaneous ulcers or nodular ulcerative lesions over the body. Presently, this disease is studied in 10 pet dogs and 73 human beings. Oriental sore was confirmed by the presence of Leishmania tropica bodies in Leishman's stained contact smears from the lesions. In case of human beings, the disease was also confirmed by cultural examination of intralesional blood in the Tobie medium (Tobie et al., 1950) for the presence of L. tropica promastigotes. Five dogs and 45 human beings were treated with berberine sulphate (2%) and 5 dogs and 28 human beings were treated with sodium antimony gluconate (10%). Both medicines were injected intralesionally @ 0.5 ml/sq. cm of skin lesion at weekly interval till recovery. In the present study, out of 10 dogs, 6 were male and 4 were female and ulcerative lesions were found on the face, snout, fore limbs and hind limbs sized from 9 to 20 mm in diameter. In human beings, male female ratio was 2.2 : 1 while in dogs, it was 1.5 : 1. In human beings almost all lesions found on exposed parts of the body and they were sized from 20 to 35 mm. In dogs, both the medicines were found equally effective except number of weekly treatments. In human beings, intralesional injections of berberine sulphate and sodium antimony gluconate were found to be 97.77% to 92.85% effective, respectively.

References

1.  Tobie et al. (1950). J. Parasit. 36: 48-54.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Anil Ahuja


MAIN : Abstracts, Oral : Cutaneous Leishmaniasis
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27